Board of Directors

Pete Leone


Pete Leone

Pete Leone, MBA, joined SeromYx’s Board of Directors in late 2019. He is life sciences entrepreneur with over twenty-five years of demonstrated success in bio-pharmaceuticals and medical devices. Pete consults with various early stage biotechs in business development and strategic transactions and serves on corporate and not-for-profit Boards. Most recently, Pete led business development efforts for Bicycle Therapeutics as Chief Business Officer.

Previously, Pete was the Vice President of Strategic Business Initiatives at Arrowhead Pharmaceuticals, where he led a $3.7 billion deal with Janssen Pharmaceuticals which included $250 million in upfront cash and equity at a premium. Before that, he was founding CEO or COO at three venture backed companies, including Mersana Therapeutics, where he focused on raising capital and building the company’s platform technology and product pipeline. In his career, Pete negotiated and managed alliances in twenty-four strategic corporate agreements and nine academic technology licenses, including a $670 million collaboration with Amgen and $340 million collaboration with Teva. He has helped several companies from inception to major value creating milestones including validating deals, INDs, clinical development, FDA clearance, payer contracting, patient advocacy, and revenues.

Early in his career, Pete worked in Systems Engineering at General Electric, in marketing at Procter & Gamble, and was a Partner at Corporate Decisions, now part of Mercer. Pete holds an A.B. in engineering science with pre-med studies from Dartmouth College and an MBA from the Stanford University Graduate School of Business.

updated: 10 months ago